In this context, the Lingwood laboratory studies B cell antibody responses to both HIV and influenza with the goal of 1) understanding how antigenic sites of vulnerability are initially perceived by specific germline B cell receptor (BCR)
sequences and 2) how that
recognition process can direct antibody
affinity maturation toward production of broadly neutralizing anti-viral responses.